CLINICAL STUDY: MYOCARDIAL ISCHEMIA
Reduction of exercise-induced myocardial ischemia during add-on treatment with the angiotensin-converting enzyme inhibitor enalapril in patients with normal left ventricular function and optimal beta blockade
Ad F. M. van den Heuvel, MDa,
Peter H. J. M. Dunselman, MD, PhDb,
Tsjerk Kingma, MSca,
Patrick Verhorst, MD, PhDc,
Frans Boomsma, PhDd,
Wiek H. van Gilst, PhDa and
Dirk J. van Veldhuisen, MD, PhD, FACCa
a Department of Cardiology/Thoraxcenter, University Hospital Groningen, Netherlands
b Ignatius Hospital, Breda, Netherlands
c Medisch Spectrum Twente, Enschede, Netherlands
d Department of Internal Medicine I/COEUR, University Hospital Dijkzigt, Rotterdam, Netherlands
Manuscript received March 17, 2000;
revised manuscript received August 12, 2000,
accepted October 2, 2000.
Reprint requests and correspondence: Prof. Dr. Dirk J. van Veldhuisen, Dept. of Cardiology/Thoraxcenter, University Hospital Groningen, P.O. Box 30001, 9700 RB Groningen, The Netherlands d.j.van_veldhuisen{at}thorax.azg.nl
OBJECTIVES
We sought to study the effect of angiotensin-converting enzyme inhibition on exercise-induced myocardial ischemia.
BACKGROUND
Although angiotensin-converting enzyme inhibitors have been shown to reduce ischemic events after myocardial infarction, few data are available regarding their direct anti-ischemic effects in patients with coronary artery disease.
METHODS
We studied 43 patients (average age 63 ± 8 years) with exercise-induced myocardial ischemia ( 0.1 mV ST depression, despite optimal beta blockade) and normal left ventricular function (ejection fraction >0.50). In a double-blind, placebo-controlled parallel design, patients were treated with angiotensin-converting enzyme inhibitor (enalapril 10 mg twice daily) or placebo. Assessments were made after three weeks (short-term) and 12 weeks (long-term).
RESULTS
At baseline, the groups were well matched for all clinical characteristics. After three weeks, there was a slight but not significant increase in time to 0.1 mV ST depression in both groups (p = NS); rate pressure product (RPP = heart rate x systolic blood pressure) was also unaffected. After 12 weeks, however, time to 0.1 mV ST depression further increased in the enalapril group (5.6 ± 1.9 min) but was unchanged in the placebo group (4.4 ± 1.3 min; p < 0.05 between groups). In contrast, RPP was not affected. Concentrations of both atrial and brain natriuretic peptides at peak exercise tended to be lower by enalapril, if compared to placebo (p = NS).
CONCLUSIONS
Angiotensin-converting enzyme inhibition may reduce exercise-induced myocardial ischemia in patients with normal left ventricular function. Further studies are needed to elucidate the mechanisms involved.
|
Abbreviations and Acronyms
| | ANP | = atrial natriuretic peptide | | BNP | = brain natriuretic peptide | | CAD | = coronary artery disease | | LV | = left ventricular | | RPP | = rate pressure product |
|
This article has been cited by other articles:

|
 |

|
 |
 
N. Danchin, M. Cucherat, C. Thuillez, E. Durand, Z. Kadri, and P. G. Steg
Angiotensin-Converting Enzyme Inhibitors in Patients With Coronary Artery Disease and Absence of Heart Failure or Left Ventricular Systolic Dysfunction: An Overview of Long-term Randomized Controlled Trials.
Arch Intern Med,
April 10, 2006;
166(7):
787 - 796.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Pepine, J.-L. Rouleau, K. Annis, A. Ducharme, P. Ma, J. Lenis, R. Davies, U. Thadani, B. Chaitman, H. E. Haber, et al.
Effects of angiotensin-converting enzyme inhibition on transient ischemia: The quinapril anti-ischemia and symptoms of angina reduction (QUASAR) trial
J. Am. Coll. Cardiol.,
December 17, 2003;
42(12):
2049 - 2059.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|